XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Adoption of new accounting pronouncement
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Adoption of new accounting pronouncement
Accumulated Deficit
Accumulated Deficit
Adoption of new accounting pronouncement
Treasury Stock
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020     25,916,168            
Beginning balance at Dec. 31, 2020 $ (96,134) $ (91,927) $ 26 $ 797,655 $ (93,475) $ (838,817) $ 1,548 $ (54,998) $ 0
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock and warrants from offering, net of issuance costs (in shares)     32,142,858            
Issuance of common stock and warrants from offering, net of issuance costs 208,730   $ 32 208,698          
Issuance of common stock, net of issuance costs (in shares)     897,364            
Issuance of common stock and warrants from offering, net of issuance costs 9,703   $ 1 9,702          
Exchange of $15 million of convertible note to equity, net of issuance costs (in shares)     1,094,848            
Exchange of convertible notes to equity, net of issuance costs 11,660   $ 1 11,659          
Exercise of stock options (in shares)     491,700            
Exercise of stock options 3,762   $ 1 3,761          
Vesting of restricted stock units (in shares)     203,344            
Vesting of restricted stock units 0                
Vesting of ESPP Shares (in shares)     133,214            
Vesting of ESPP Shares 2,095     2,095          
Stock-based compensation 24,306     24,306          
Other comprehensive gain (loss) (31)               (31)
Net loss (269,108)         (269,108)      
Ending balance (in shares) at Dec. 31, 2021     60,879,496            
Ending balance at Dec. 31, 2021 (196,944)   $ 61 964,401   (1,106,377)   (31) (54,998)
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock, net of issuance costs (in shares)     13,043,797            
Issuance of common stock and warrants from offering, net of issuance costs $ 90,848   $ 13 90,835          
Exercise of stock options (in shares) 0                
Vesting of restricted stock units (in shares)     440,697            
Vesting of restricted stock units $ 1   $ 1            
Vesting of ESPP Shares (in shares)     206,208            
Vesting of ESPP Shares 732     732          
Stock-based compensation 15,215     15,215          
Other comprehensive gain (loss) 29               29
Net loss (233,659)         (233,659)      
Ending balance (in shares) at Dec. 31, 2022     74,570,198            
Ending balance at Dec. 31, 2022 $ (323,778)   $ 75 $ 1,071,183   $ (1,340,036)   $ (2) $ (54,998)